Disposable, auto, reusable, metal, single-use and dual-chamber — each specified for your therapy.
Nine platforms, alternating layout. Specifications shown for each — click a pen to open its detailed page.
Intended applications and dose ranges are determined by the final registered labeling for each market.
Intended applications and dose ranges are determined by the final registered labeling for each market.
Intended applications and dose ranges are determined by the final registered labeling for each market.
Intended applications and dose ranges are determined by the final registered labeling for each market.
Intended applications and dose ranges are determined by the final registered labeling for each market.
Intended applications and dose ranges are determined by the final registered labeling for each market.
Intended applications and dose ranges are determined by the final registered labeling for each market.
Intended applications and dose ranges are determined by the final registered labeling for each market.
Intended applications and dose ranges are determined by the final registered labeling for each market.
Alongside the pens, we source and coordinate a full range of ready-to-order components — sterile pen needles, ready-to-use glass cartridges, complete packaging (design through production), and raw materials — through vetted partner factories. One factory, one point of contact, one accountable supply chain.
One partner across pens, needles, cartridges, packaging and raw materials — no supplier juggling.
One supply chain, one accountability, fewer handoffs between vendors.
Pens and components arrive matched to your dose, branding and target market.
Certifications (CE, ISO 13485, GMP) documented for every component.
Tell us which pens you are specifying — we will send samples, specifications and a one-stop quote.
Waytop is a wholesale supplier of injection pens and related components. Regulatory market entry, local certifications and compliance are the buyer's responsibility. Waytop does not sell into markets where a given model is subject to an existing authorized distributor or patent. Intended applications and all clinical statements are determined by the final registered labeling for each market.